ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Life Sciences BC 2025-26 Board of Directors Announcement

Life Sciences BC (LSBC) is pleased to announce new and returning members to the Board of Directors following its Annual General Meeting (AGM) on September 17, 2025. The Board of Directors is comprised of seasoned leaders dedicated to driving forward the growth of the life sciences sector.

New and Returning Board Members and Observers

LSBC welcomes Christina Zacharuk, CEO of Research Universities’ Council of British Columbia, and Sandra Wong, Senior Manager, Access and Government Affairs of Pfizer Canada, who were each elected to three-year terms.

Anne Stevens, VP Business Development of AbCellera, Michael Martin, Global Biopharmaceutical Executive, and Suzanne Gill, President & CEO of Genome British Columbia, were each re-elected to three-year terms.

At the Board Meeting following the AGM, Hector MacKay-Dunn, KC, Joseph Garcia, and Roger Kuypers received renewed one-year appointments as Board Observers.

The full slate of LSBC’s Board of Directors is listed below. To learn more about our current board members, please visit our website: https://lifesciencesbc.ca/about-us/board-directors/

LSBC Board Directors – Executive Committee

  • Chair: Anne Stevens, VP Business Development, AbCellera
  • Vice-Chair: Lana Janes, Co-Founder & COO, Abdera Therapeutics
  • Treasurer: Rajveer Hundal, Partner, PWC Canada

LSBC Board Directors

  • Ali Ardakani, Founder & Managing Director, Novateur Ventures, Co-Founder & CEO of Optigo Biotherapeutics
  • Sherry Aulin, Life Sciences Executive Leader (former CFO Xenon)
  • Kevin Chaplin, CEO, Kardium
  • Tom Frohlich, CEO, Jade Biosciences
  • Suzanne Gill, President & CEO of Genome British Columbia
  • David Helliwell, Co-Founder & Executive Board Chair, Thrive Health
  • Wendy Hurlburt, President & CEO, Life Sciences BC
  • Michael Martin, Global Biopharmaceutical Executive
  • Scott Phillips, President, Starfish Medical
  • David Poon, Co-Founder, Head of Corporate Development, DCx
  • Sandra Wong, Senior Manager, Access and Government Affairs, Pfizer Canada
  • Christina Zacharuk, CEO of Research Universities’ Council of British Columbia
  • Peter Zandstra, Professor & Director, UBC School of Biomedical Engineering

LSBC Board Observers

  • Joseph Garcia, Partner, Blake, Cassels & Graydon LLP
  • Roger Kuypers, Partner, Fasken, Martineau, Dumoulin LLP
  • Hector MacKay-Dunn, KC, Senior Partner, Farris, Vaughan, Wills & Murphy LLP

Past Board Members

LSBC would like to thank our outgoing Board Directors for their service and leadership over the past years.

  • Max Blouw, Former President, Research Universities Council of BC,

    LSBC Board Director for 4 years
  • Bev Holmes, President & CEO, Health Research BC,

    LSBC Board Director for 3 years
  • David Llewellyn, President and CEO, Trailhead Biosystems,

    LSBC Board Director for 7 years

About Life Sciences BC

Life Sciences BC (LSBC) is a not-for-profit sector association dedicated to advancing British Columbia’s life sciences ecosystem through strategic initiatives at the local, national, and international levels. We drive economic growth in the province by providing leadership, fostering investment and partnerships, collaborating with government, and promoting BC’s world-class life sciences sector.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.